A Phase III Double-Blind, Randomized, Placebo-Controlled Study of Erythropoietin When Used as an Adjuvant to Radiation Therapy in Patients With Head & Neck Squamous Cell Carcinoma
Primary Sponsor
EORTC
Collaborating Groups
TROG Cancer Research
Related Post
24 February, 2026
First patient recruited for trial of new imaging modality for lung cancer
LATEST NEWS: 24 February 2026 The first Australian participant
